Clinical Trial Update: The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating tadalafil as an adjunct to antidepressants for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Sadat City University | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: WITHDRAWN